HRH2 | Histamine receptor H2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ICAM4 | Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IFNG | Interferon, gamma | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IL18RAP | Interleukin 18 receptor accessory protein | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL1B | Interleukin 1, beta | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
IQGAP3 | IQ motif containing GTPase activating protein 3 | Plasma proteins
| | | | | Tissue enhanced |
IRAK3 | Interleukin-1 receptor-associated kinase 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KCNH2 | Potassium voltage-gated channel, subfamily H (eag-related), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KEL | Kell blood group, metallo-endopeptidase | Blood group antigen proteins Cancer-related genes CD markers Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
KIAA0101 | KIAA0101 | Mitochondrial proteins
| | | | | Tissue enhanced |
KIF21B | Kinesin family member 21B | Plasma proteins
| | | | | Tissue enhanced |
KLHL15 | Kelch-like family member 15 | | | | | | Tissue enhanced |
KRT86 | Keratin 86 | Disease related genes
| | | | | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LILRA2 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LILRA3 | Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | CD markers Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LILRA5 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
LIN7A | Lin-7 homolog A (C. elegans) | | | | | | Tissue enhanced |
LPPR3 | Hsa-mir-3187 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
LTF | Lactotransferrin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LYL1 | Lymphoblastic leukemia derived sequence 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
M1AP | Meiosis 1 associated protein | | | | | | Tissue enhanced |
MKI67 | Marker of proliferation Ki-67 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MXD3 | MAX dimerization protein 3 | Transcription factors
| | | | | Tissue enhanced |
MYB | V-myb avian myeloblastosis viral oncogene homolog | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
MYO1G | Myosin IG | | | | | | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes
| | | | | Tissue enhanced |
NCF4 | Neutrophil cytosolic factor 4, 40kDa | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
NFAM1 | NFAT activating protein with ITAM motif 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NFKBID | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta | Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
NKG7 | Natural killer cell group 7 sequence | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NLRP12 | NLR family, pyrin domain containing 12 | Disease related genes
| | | | | Tissue enhanced |
NLRP3 | NLR family, pyrin domain containing 3 | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
NRROS | Negative regulator of reactive oxygen species | Predicted membrane proteins
| | | | | Tissue enhanced |
NTSR1 | Neurotensin receptor 1 (high affinity) | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OASL | 2'-5'-oligoadenylate synthetase-like | | | | | | Tissue enhanced |
OR2W3 | Olfactory receptor, family 2, subfamily W, member 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ORC1 | Origin recognition complex, subunit 1 | Disease related genes
| | | | | Tissue enhanced |
OSBP2 | Oxysterol binding protein 2 | | | | | | Tissue enhanced |
OSCAR | Osteoclast associated, immunoglobulin-like receptor | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OSM | Oncostatin M | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OTOF | Otoferlin | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PDE4D | Phosphodiesterase 4D, cAMP-specific | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
PF4V1 | Platelet factor 4 variant 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PIK3CG | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | Cancer-related genes Enzymes RAS pathway related proteins
| | | | | Tissue enhanced |
PIK3R5 | Phosphoinositide-3-kinase, regulatory subunit 5 | Disease related genes RAS pathway related proteins
| | | | | Tissue enhanced |